Several Northeast Ohio Med Spas Get Blasted by Ohio Attorney General

April 17, 2025

Ohio Attorney General Dave Yost announced Wednesday he sent letters to 14 medical spas, many in Northeast Ohio, warning them to stop making false or misleading claims about their versions of popular weight-loss drugs.

With the popularity of FDA approved drugs such as Ozempic, Wegovy, Zepbound and Mounjaro, several health spas are offering compounds of the active ingredient in those drugs to customers.

According to Yost, compound drugs like semaglutide and/or tirzepatide have not been tested and approved by the FDA, and some spas are advertising them as just as safe and effective.

Read more at Cleveland 19 News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications